Announced Mon, 22 Jun · 12:05 IST
Trading window closure ahead of Q1FY27 results
Compliance View source PDF
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹65.10
prior close
₹66.70
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+2.0+1.8+1.8-7.0-6.6-9.8-16.5-18.0——
Up moveDown movePending
AI summary
Krebs Biochemicals has closed its trading window from close of business on June 30, 2026 until 48 hours after declaration of unaudited financial results for Q1FY27 (quarter ended June 30, 2026). The restriction applies to promoters, directors, designated persons, their immediate relatives, and all connected persons under SEBI insider trading regulations. The board meeting date to approve Q1 results will be communicated separately. This is a standard compliance intimation.
Likely market impact
Routine SEBI compliance filing with no direct impact on stock. Indicates upcoming Q1FY27 results announcement.